A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable ...
A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable ...
RNA interference using small interfering RNAs (siRNAs) has become a mainstay of functional gene characterization and has ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
The Midwest hospital system aims to embed genetic testing into everyday care for heart disease and discover new genetic risk ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
The rapid expansion of genomic technologies has transformed oncology, enabling comprehensive profiling of tumor DNA at unprecedented scale. Yet, the ...
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial Multiple myeloma (MM) is consistently preceded by monoclonal gammopathy ...
Advances in genomic medicine services in the NHS offer an unprecedented opportunity to determine the genetic basis of thousands of undiagnosed rare diseases and improve care. For experts to make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback